EnteroBiotix secures £19M to support IBS microbiome clinical trial
EnteroBiotix secures £19M to support IBS microbiome clinical trial Glasgow-based life sciences company EnteroBiotix has secured £19 million in funding to support the advancement of its microbiome-based therapies, including a large-scale clinical trial targeting irritable bowel syndrome (IBS). The round was led by Thairm Bio and the Scottish National Investment Bank,
